{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T20:41:05Z","timestamp":1661805665602},"reference-count":0,"publisher":"Harborside Press, LLC","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JADPRO"],"published-print":{"date-parts":[[2022,8,1]]},"abstract":"<jats:p>P. Andrew Allred, MS, PA-C, of Banner MD Anderson Cancer Center, considers data on managing newly diagnosed MM and CAR T-cell therapy in MM. Amy Pierre, MSN, ANP-BC, of MSKCC and Flatiron Health, reviews findings on telemedicine inequities and real-world data on axicabtagene ciloleucel. Meredith Beaton, MSN, RN, of UCHealth, evaluates data on FLT3-mutated AML and TKI discontinuation in CML. Pamela Lee, NP, MSN, of UCSF Medical Center, analyzes results of a new BiTE therapy in DLBCL and CAR T-cell therapy in MCL. Amber Koehler, PA-C, of Mayo Clinic Cancer Center, reviews combination therapies for CLL.<\/jats:p>","DOI":"10.6004\/jadpro.2022.13.6.9","type":"journal-article","created":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T20:21:32Z","timestamp":1661804492000},"page":"618-632","source":"Crossref","is-referenced-by-count":0,"title":["Hematologic Malignancies: 2022 ASCO Annual Meeting Highlights for the Advanced Practitioner"],"prefix":"10.6004","volume":"13","author":[{"given":"P. Andrew","family":"Allred, MS, PA-C","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy","family":"Pierre, MSN, ANP-BC","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meredith","family":"Beaton, MSN, RN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pamela","family":"Lee, NP, MSN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amber","family":"Koehler, PA-C","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"4047","published-online":{"date-parts":[[2022,8,1]]},"container-title":["Journal of the Advanced Practitioner in Oncology"],"original-title":[],"deposited":{"date-parts":[[2022,8,29]],"date-time":"2022-08-29T20:21:46Z","timestamp":1661804506000},"score":1,"resource":{"primary":{"URL":"https:\/\/advancedpractitioner.com\/issues\/volume-13,-number-6-(aug-2022)\/hematologic-malignancies-2022-asco-annual-meeting-highlights-for-the-advanced-practitioner.aspx"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,8,1]]},"references-count":0,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2022,8,1]]},"published-print":{"date-parts":[[2022,8,1]]}},"URL":"https:\/\/doi.org\/10.6004\/jadpro.2022.13.6.9","relation":{},"ISSN":["2150-0878"],"issn-type":[{"value":"2150-0878","type":"print"}],"subject":[],"published":{"date-parts":[[2022,8,1]]}}}